Article
Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2006
Willmore-Payne Carlynn, Holden Joseph A, Layfield Lester J
Abstract excerpt
Recent reports have indicated that mutations in the epidermal growth factor receptor-1 (EGFR) occur in about 7% of patients with squamous cell carcinoma of the head and neck. It is known that many patients with non-small-cell lung cancer who respond to the EGFR inhibitors gefitinib and erlotinib have tumors with EGFR-activating mutations. This might suggest that patients with head and neck squamous carcinoma, who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
